Quantcast

Latest Pharmaceutical industry in India Stories

2014-04-07 08:30:43

BOSTON, April 7, 2014 /PRNewswire/ -- Piramal Enterprises' Pharma Solutions Division, a global pharmaceutical contract development and manufacturing organization (CDMO), has received CMO Leadership Awards 2013 in two categories - Quality and Reliability, at a prestigious ceremony at DCAT in New York. Within the Reliability category, Piramal has been recognized as the most "Reliable" CMO among the 5 CMOs shortlisted for this award. (Logo:...

2014-04-04 12:27:58

DUBLIN, Apr. 04, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/8mt3ng/membrane ) has announced the addition of the "Membrane Technology Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2019" report to their offering. (Logo:http://photos.prnewswire.com/prnh/20130307/600769) Globally, the membrane technology market is witnessing significant growth due to increasing research and development and production in...

2014-04-03 08:29:12

Financing to Support Entry of OPI's Lead Product Candidate - NHPN-1010 - into Clinical Testing First Half of 2014 OKLAHOMA CITY, April 3, 2014 /PRNewswire/ -- Accele Venture Partners, the investing arm of life sciences accelerator Accele Biopharma, Inc., announced today that it has co-led a $4.1 million Series A private equity financing of Otologic Pharmaceutics, Inc. (OPI), a development-stage biopharmaceutical company committed to developing and commercializing novel...

2014-04-02 04:21:07

LAUSANNE, Switzerland and HAMBURG, Germany, April 2, 2014 /PRNewswire/ -- - Innovative partnership based on Evotec's Target X projects - Evotec and Debiopharm to share discovery and development efforts Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) announced today a research collaboration and licensing deal with Debiopharm Group(TM), Lausanne, Switzerland. The objective of this collaboration is to identify and...

2014-04-01 08:29:32

WOODCLIFF LAKE, N.J., April 1, 2014 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. today announced that Terrance J. Coughlin has been named chief operating officer. In this capacity, Mr. Coughlin will be responsible for Par's global manufacturing activities, research and development efforts and will be instrumental in the new product selection process. Mr. Coughlin joins Par from Glenmark Generics, Inc. USA/Glenmark Generics Limited where he most recently served as president...

2014-04-01 08:28:47

DUBLIN, April 1, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today announced that it has successfully completed the divestiture of its generics commercial operations in seven markets in Western Europe to Aurobindo Pharma Limited (BSE: 524804). The agreement to divest the commercial operations was announced in January 2014. http://photos.prnewswire.com/prnvar/20130124/NY47381LOGO Aurobindo acquired Actavis' pharmaceutical commercial infrastructure in France, Italy, Spain,...

2014-03-31 23:37:07

Top Tier Panelists from Onyx Pharmaceuticals, BioMarin Pharmaceutical, San Francisco State University, and Clinovo Share Experience on How to Conduct Successful Outsourcing Strategies Sunnyvale, CA (PRWEB) March 31, 2014 Outsourcing experts from Onyx Pharmaceuticals, San Francisco State University (SFSU), BioMarin Pharmaceutical, and Clinovo discussed the topic 'Manage In-house and Outsourced Clinical Trials: Vendor Selection, Project Coordination, and Resource Management' at the...

2014-03-31 04:20:51

CAMBRIDGE, England, March 31, 2014 /PRNewswire/ -- Convergence Pharmaceuticals Holdings Limited ("Convergence"), the company focused on the development of novel and high value analgesic medicines for the treatment of chronic pain, today announces that it has entered into a research alliance with Evotec, a drug discovery alliance and development partnership company focused on rapidly progressing innovative product approaches with leading pharmaceutical and biotechnology...

2014-03-24 23:24:35

MarketOptimizer.org offers “PharmaPoint: Type 2 Diabetes – Global Drug Forecast and Market Analysis to 2022 – Event-Driven Update” to its store. Dallas, Texas (PRWEB) March 24, 2014 This report focuses on type 2 diabetes pharmaceuticals in seven major markets (US, France, Germany, Italy, Spain, UK, and Japan) and three emerging markets (China, India and Brazil). These 10 markets will be referred to as the global market. The global type 2 diabetes pharmaceutical markets in the 2012...

2014-03-14 12:28:10

GHENT, Belgium, March 14, 2014 /PRNewswire/ -- ActoGeniX NV, creator of ActoBiotics(TM), announced today that Bernard Coulie, Chief Executive Officer, will present a company overview at the 21(st )Annual Future Leaders in the Biotech Industry Conference at 1:30pm ET on Friday, March 28, 2014, at the Millennium Broadway Hotel in New York City. A live webcast of the presentation will be available at the following link: https://www.webcaster4.com/Webcast/Page/392/3742 and on the...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.